Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
Sievi 
17.12.21 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€32.60
16.12.21
-
16.12.22
38.19%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
16.12.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
16.12.21 60%
sell
MagForce AG

Start price
Target price
Perf. (%)
€2.87
15.12.21
-
15.12.22
-99.93%
16.12.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
High valuation
Risky balance sheet
Amped 
15.12.21 0%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€0.98
14.12.21
-
14.12.22
-39.08%
15.12.22

Could be worthwhile Investment >10% per year
melinda 
14.12.21 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.28
14.12.21
€0.000
14.12.22
-99.89%
20.02.22

Could be worthwhile Investment >10% per year
melinda 
14.12.21 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.89
12.12.21
-
12.12.22
7.45%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
11.12.21 100%
sell
Epizyme Inc.

Start price
Target price
Perf. (%)
€2.63
11.12.21
-
11.12.22
-45.63%
08.12.22

Probably not worthwhile Investment
Lokrim 
11.12.21 20%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
Lokrim 
11.12.21 20%
buy
Senseonics Holdings Inc

Start price
Target price
Perf. (%)
€2.55
10.12.21
€10.00
31.12.23
-63.92%
11.06.22

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
nefets 
10.12.21 70%
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€7.05
08.12.21
-
08.12.22
-4.99%
12.12.21

Risky Investment
thomasw 
08.12.21 50%
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
melinda 
08.12.21 50%
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.90
07.12.21
-
07.12.22
4.24%
11.12.21

Risky Investment
Wolf_of_WS 
07.12.21 50%
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.60
06.12.21
€2.80
06.12.22
-1.25%
07.12.22

Could be worthwhile Investment >10% per year
melinda 
06.12.21 50%